Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled β -agonist treatment
Authors:
- J.O. CowanJCJ.O. Cowan
- E.M. FlanneryEFE.M. Flannery
- G.P. HerbisonGHG.P. Herbison
- C.R. MclachlanCMC.R. Mclachlan
- D.R. TaylorDTD.R. Taylor
- 1 August 2000
- journal article
- clinical trial
- Published by Elsevier in Respiratory Medicine
- Vol. 94 (8) , 767-771
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Tolerance to beta-agonists during acute bronchoconstrictionEuropean Respiratory Journal, 1999
- Randomised trial of an inhaled beta 2 agonist, inhaled corticosteroid and their combination in the treatment of asthmaThorax, 1999
- Functional antagonism: tolerance produced by inhaled beta 2 agonists.Thorax, 1996
- Rebound Airway Obstruction and Responsiveness After Cessation of Terbutaline: Effects of BudesonideAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Beta-Adrenergic Receptors and Their RegulationAmerican Journal of Respiratory and Critical Care Medicine, 1995
- Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patientsThe Lancet, 1995
- Subsensitivity of bronchodilator and systemic beta 2 adrenoceptor responses after regular twice daily treatment with eformoterol dry powder in asthmatic patients.Thorax, 1995
- Bronchodilator subsensitivity after chronic dosing with eformoterol in patients with asthmaThe American Journal of Medicine, 1994
- Asthma Control during and after Cessation of Regular Beta2-Agonist TreatmentAmerican Review of Respiratory Disease, 1993
- REBOUND INCREASE IN BRONCHIAL RESPONSIVENESS AFTER TREATMENT WITH INHALED TERBUTALINEThe Lancet, 1988